International Psoriasis Council
Advancing Knowledge. Improving Care.
Welcome and Introduction
Akimichi Morita, MD, PhD, Japan
Genetic Insights into IBD and Psoriasis: Shared Features and Unique Characteristics
Alex Tsoi, MS, PhD, United States
Immunopathogenesis of IBD: Pathways and Therapeutic Challenges
Kiyoshi Takeda, MD, PhD, Japan
Case Study: The Complex Relationship between IBD and Psoriasis
Francis Lai, MBBS, FACD, Australia
Panel Discussion
Faculty
Closing Comments and Adjourn
Akimichi Morita, MD, PhD, Japan
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.
